The CONFIDENT study protocol: a randomized controlled trial comparing two methods to increase long-term care worker confidence in the COVID-19 vaccines.

Détails

Ressource 1Télécharger: 36823559_BIB_1F64B5DC9E0F.pdf (2107.93 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_1F64B5DC9E0F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The CONFIDENT study protocol: a randomized controlled trial comparing two methods to increase long-term care worker confidence in the COVID-19 vaccines.
Périodique
BMC public health
Auteur⸱e⸱s
Stevens G., Johnson L.C., Saunders C.H., Schmidt P., Sierpe A., Thomeer R.P., Little N.R., Cantrell M., Yen R.W., Pogue J.A., Holahan T., Schubbe D.C., Forcino R.C., Fillbrook B., Sheppard R., Wooten C., Goldmann D., O'Malley A.J., Dubé E., Durand M.A., Elwyn G.
ISSN
1471-2458 (Electronic)
ISSN-L
1471-2458
Statut éditorial
Publié
Date de publication
23/02/2023
Peer-reviewed
Oui
Volume
23
Numéro
1
Pages
384
Langue
anglais
Notes
Publication types: Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Clinical and real-world effectiveness data for the COVID-19 vaccines have shown that they are the best defense in preventing severe illness and death throughout the pandemic. However, in the US, some groups remain more hesitant than others about receiving COVID-19 vaccines. One important group is long-term care workers (LTCWs), especially because they risk infecting the vulnerable and clinically complex populations they serve. There is a lack of research about how best to increase vaccine confidence, especially in frontline LTCWs and healthcare staff. Our aims are to: (1) compare the impact of two interventions delivered online to enhanced usual practice on LTCW COVID-19 vaccine confidence and other pre-specified secondary outcomes, (2) determine if LTCWs' characteristics and other factors mediate and moderate the interventions' effect on study outcomes, and (3) explore the implementation characteristics, contexts, and processes needed to sustain a wider use of the interventions.
We will conduct a three-arm randomized controlled effectiveness-implementation hybrid (type 2) trial, with randomization at the participant level. Arm 1 is a dialogue-based webinar intervention facilitated by a LTCW and a medical expert and guided by an evidence-based COVID-19 vaccine decision tool. Arm 2 is a curated social media web application intervention featuring interactive, dynamic content about COVID-19 and relevant vaccines. Arm 3 is enhanced usual practice, which directs participants to online public health information about COVID-19 vaccines. Participants will be recruited via online posts and advertisements, email invitations, and in-person visits to care settings. Trial data will be collected at four time points using online surveys. The primary outcome is COVID-19 vaccine confidence. Secondary outcomes include vaccine uptake, vaccine and booster intent for those unvaccinated, likelihood of recommending vaccination (both initial series and booster), feeling informed about the vaccines, identification of vaccine information and misinformation, and trust in COVID-19 vaccine information provided by different people and organizations. Exploration of intervention implementation will involve interviews with study participants and other stakeholders, an in-depth process evaluation, and testing during a subsequent sustainability phase.
Study findings will contribute new knowledge about how to increase COVID-19 vaccine confidence and effective informational modalities for LTCWs.
NCT05168800 at ClinicalTrials.gov, registered December 23, 2021.
Mots-clé
Humans, COVID-19/prevention & control, COVID-19 Vaccines, SARS-CoV-2, Long-Term Care, Vaccines, Randomized Controlled Trials as Topic, COVID-19, COVID-19 vaccines, Dialogue-based, Intervention, Long-term care workers, Shared decision-making, Social media, Trial protocol, Vaccine confidence, Vaccine hesitancy
Pubmed
Web of science
Open Access
Oui
Création de la notice
02/03/2023 16:37
Dernière modification de la notice
23/01/2024 8:21
Données d'usage